MSKCC receives $400M gift from Kenneth Griffin & David Geffen

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Every summer since 2010, ten undergraduate students from diverse backgrounds get the opportunity to explore any curiosities they might have about careers in medicine at Memorial Sloan Kettering Cancer Center.

October 04, 2024

Vol.50 No.37

By Claire Marie Porter

In Brief

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Four NCI-designated cancer centers—Dana-Farber Cancer Institute, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center, and The Sidney Kimmel Comprehensive Cancer Center and Whiting School of Engineering at Johns Hopkins—have joined together and secured funding from AWS, Deloitte, Microsoft, and NVIDIA, to create the Cancer AI Alliance.

October 04, 2024

Vol.50 No.37

Clinical

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

A meta-analysis of 25 studies—totaling over 5,000 participants—focused on a question that has been troubling patients, physicians, and regulators: Does treatment with CAR T-cell therapy contribute to the development of secondary cancers?

September 13, 2024

Vol.50 No.34

By McKenzie Prillaman

In Brief

Nancy Hanley Eriksson, Kevin Conroy receive TGen’s John S. McCain Leadership Awards

Nancy Hanley Eriksson and Kevin Conroy received John S. McCain Leadership Awards from Translational Genomics Research Institute (TGen), part of City of Hope, at the institute’s 2024 Founders Dinner, an annual gathering held April 4 in Scottsdale, AZ.

April 12, 2024

Vol.50 No.15

In Brief

Ellen Sigal, Marlene Malek, Scott LaGanga, Tim Lawrence to receive advocacy, philanthropy awards by Georgetown Lombardi

Ellen V. Sigal, Marlene A. Malek, Scott LaGanga, and Tim Lawrence will be honored at the 36th Annual Lombardi Gala, an annual event dedicated to raising funds for Georgetown University’s Lombardi Comprehensive Cancer Center.

April 05, 2024

Vol.50 No.14

Daniel Snyder, former Washington Commanders owner, donates riverfront “château” to ACS

After a year of trying to sell his mansion, former Washington Commanders owner Daniel Snyder opted to donate it to the American Cancer Society.

March 29, 2024

Vol.50 No.13

By Jacquelyn Cobb

MSKCC receives $400M gift from Kenneth Griffin & David Geffen

YOU MAY BE INTERESTED IN

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

Nancy Hanley Eriksson, Kevin Conroy receive TGen’s John S. McCain Leadership Awards

Ellen Sigal, Marlene Malek, Scott LaGanga, Tim Lawrence to receive advocacy, philanthropy awards by Georgetown Lombardi

Daniel Snyder, former Washington Commanders owner, donates riverfront “château” to ACS

Renew today!

Subscriber content

MSKCC receives $400M gift from Kenneth Griffin & David Geffen

YOU MAY BE INTERESTED IN

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Dana-Farber, Fred Hutch, MSK, Hopkins form Cancer AI Alliance

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis showsSubgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies

Nancy Hanley Eriksson, Kevin Conroy receive TGen’s John S. McCain Leadership Awards

Ellen Sigal, Marlene Malek, Scott LaGanga, Tim Lawrence to receive advocacy, philanthropy awards by Georgetown Lombardi

Daniel Snyder, former Washington Commanders owner, donates riverfront “château” to ACS

Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies